SHOULDER INNOVATIONS, INC. (SI) Latest Filing Signal

Based on earningsVibe SuperAnalyst™ synthesis of the latest 10-K, SHOULDER INNOVATIONS, INC.'s filing signal turned negative.

Shoulder Innovations, Inc. is a commercial-stage medical technology company focused on the shoulder surgical care market, offering advanced implant systems for shoulder arthroplasty. The company's ecosystem includes enabling technologies like its ProVoyance preoperative planning software, efficient instrument systems, specialized support, and surgeon-to-surgeon collaboration, all designed to address clinical and operational challenges in shoulder surgery. The company estimates the global annual shoulder arthroplasty market to be approximately $2.7 billion, with the U.S. market representing $1.7 billion in 2025 and projected to grow at 11% annually through 2029. Shoulder Innovations aims to capture significant share by differentiating through its innovative, patient-centric ecosystem and a specialized commercial organization.

Revenue is primarily driven by the sale of Anatomic Total Shoulder Arthroplasty (aTSA) and Reverse Total Shoulder Arthroplasty (rTSA) implant systems, which include InSet Glenoid and humeral stem products. The company sells these implants to hospitals, outpatient centers, and Ambulatory Surgery Centers (ASCs) in the United States.